Predicting and monitoring the organ compatibility for transplantation

Test principle

SirYus technology opens the way for novel solutions to assess receivers reactions towards their transplant in order to drastically reduce rejection.

Innobiochips has developed a biochip dedicated HLA markers (cell surface proteins) and HLA antibodies detection.

Based on SirYus biochips (96 antigens of Class I  and 62 of Class II), this HLA immunoassay specifically identifiesanti-HLA antibodies to predict compatibility and avoid acute rejection.

This SirYus technology application is being developed with Itwo german partners.

This solutions enables to automate a today partially manual process and to yield more reliable and accurate biological data.